Loading...
Derniers dépôts
-
-
-
-
-
Francesco Galli, Laricia Bragg, Maira Rossi, Daisy Proietti, Laura Perani, et al.. Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy. EMBO Molecular Medicine, 2024, 16 (4), pp.927 - 944. ⟨10.1038/s44321-024-00031-3⟩. ⟨hal-04603972⟩
-
-
-
Julia Pereira Lemos, Liliane Patrícia Gonçalves Tenório, Vincent Mouly, Gillian Butler-Browne, Daniella Arêas Mendes-Da-Cruz, et al.. T cell biology in neuromuscular disorders: a focus on Duchenne Muscular Dystrophy and Amyotrophic Lateral Sclerosis. Frontiers in Immunology, 2023, 14, pp.120283. ⟨10.3389/fimmu.2023.1202834⟩. ⟨hal-04603915⟩
-
-
-
-
Angelos Gerassimopoulos, Céline Michaud, Mélanie Gaillet, Cyril Rousseau, Adriana Gonzalez, et al.. Santé et recours aux soins et à la prévention des travailleuses du sexe dominicaines vivant le long du fleuve Maroni. 6e journées des travaux scientifiques des soignant.e.s de Guyane, May 2023, Cayenne, Guyane française. ⟨hal-04585175⟩
-
Joe-Elie Salem, Marie Bretagne, Baptiste Abbar, Sarah Leonard-Louis, Stéphane Ederhy, et al.. Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis. Cancer Discovery, 2023, 13 (5), pp.1100-1115. ⟨10.1158/2159-8290.CD-22-1180⟩. ⟨hal-04578810⟩
-
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Vanessa Ueberschlag-Pitiot, Amalia Stantzou, Julien Messéant, Megane Lemaitre, Daniel Owens, et al.. Gonad-related factors promote muscle performance gain during postnatal development in male and female mice. AJP - Endocrinology and Metabolism, 2017, 313 (1), pp.E12-E25. ⟨10.1152/ajpendo.00446.2016⟩. ⟨hal-03677800⟩
-
-
-
Hubert Smeets, Bram Verbrugge, Xavier Bulbena, Liliya Hristova, Julia Vogt, et al.. European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy March 17–19, 2023, Barcelona, Spain. LAMA2-muscular dystrophy: paving the road to therapy, Neuromuscular Disorders, 36, pp.16 - 22, 2024, ⟨10.1016/j.nmd.2024.01.001⟩. ⟨hal-04546346⟩
-
Nombre de documents
790
Nombre de notices
1 380
widget_cloud
Antisense oligonucleotides
Trinucleotide repeat expansion
Satellite cells
Fabry disease
Alternative splicing
Neuromuscular diseases
Congenital muscular dystrophy
Exercise
Mouse model
PABPN1
Long read sequencing
Myotonic Dystrophy
DMD
Autoantibodies
Dilated cardiomyopathy
Lamin A/C
Neuromuscular junction
Biomarker
Myotonic Dystrophy type 1
Thymus
Myositis
Myotonic dystrophy
Laminopathies
ALS
LMNA gene
Male
Motoneuron
Actin
Fibrosis
Laminopathie
Cancer
Myoblasts
Muscular dystrophy
Dermatomyositis
Dynamin 2
Myasthenia gravis
Regeneration
Myopathy
Calcium
Outcome measures
CTG repeat contractions
Gene therapy
Satellite cell
Neuromuscular disease
Muscle regeneration
CRISPRi
Myotonic dystrophy type 1
Autoimmunity
Diagnosis
Inflammation
Cardiomyopathy
Dystrophin
Astrocyte
Rare neuromuscular diseases
CMS
Genotype phenotype correlation
FSHD
MBNL
Muscle
Treatment
Transgenic mouse model
Rare diseases
Glutamate
Centronuclear myopathy
COVID-19
OPMD
Therapy
Autoimmune diseases
AAV
Thérapie génique
Cytokines
LMNA
Mechanotransduction
RNA biology
Aging
Heart
Errance diagnostique
Laminopathy
Brain
Aged
Animals
Becker muscular dystrophy
Myasthenia Gravis MG
Amyotrophic lateral sclerosis
Humans
Myogenesis
Nuclear envelope
Cytoskeleton
Autophagy
RNA interference
Cell therapy
Lamin A/C LMNA gene
Clinical trials
Duchenne muscular dystrophy
Skeletal muscle
Congenital myopathy
Biomarkers
Transcriptomics
Myopathies
Heart failure